Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Completed · Phase 3 · Has a placebo group

Conditions studied: Hypoactive Sexual Desire Disorder

In brief

The objective of this study is to evaluate the persistence of benefit of LibiGel (testosterone gel) 300 mcg/day compared to placebo gel in a 12 week post-treatment period of Hypoactive Sexual Desire Disorder (HSDD) in surgically menopausal women.

Key facts

Study ID

NCT01235754

Run by

BioSante Pharmaceuticals

People needed

626

Starts

2010-10-01

Expected to finish

2012-01-01

Last updated by the study team

2013-01-10

Who can join

Age: 30 and older, up to 66. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• must have completed a minimum of 22 weeks of the 24-week TESTW006 or TESTW008 clinical trial

You may not qualify if…

• Any condition (including a change in sexual or relationship history) that would make the subject unsuitable for participation in the trial in the opinion of the Investigator

Where it is running

• BioSante Site #014 — Huntsville, Alabama, United States
• BioSante Site #146 — Mobile, Alabama, United States
• BioSante Site #171 — Chandler, Arizona, United States
• BioSante Site #145 — Glendale, Arizona, United States
• BioSante Site #027 — Glendale, Arizona, United States
• BioSante Site #121 — Phoenix, Arizona, United States
• BioSante Site #137 — Tucson, Arizona, United States
• BioSante Site #052 — Hot Springs, Arkansas, United States
• BioSante Site #155 — Little Rock, Arkansas, United States
• BioSante Site #221 — Berkeley, California, United States
• BioSante Site #182 — Buena Park, California, United States
• BioSante Site #162 — Sacramento, California, United States
• BioSante Site #008 — San Diego, California, United States
• BioSante Site #159 — Walnut Creek, California, United States
• BioSante Site #007 — Denver, Colorado, United States
• BioSante Site #026 — Lakewood, Colorado, United States
• BioSante Site #132 — New Britain, Connecticut, United States
• BioSante Site #151 — New London, Connecticut, United States
• BioSante Site #036 — Ridgefield, Connecticut, United States
• BioSante Site #143 — Jacksonville, Florida, United States
• BioSante Site #024 — Miami, Florida, United States
• BioSante Site #111 — Orlando, Florida, United States
• BioSante Site #219 — Pinellas Park, Florida, United States
• BioSante Site #041 — St. Petersburg, Florida, United States
• BioSante Site #095 — Hoover, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.